Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesMIL:1A 70 PS Ratio is 5.40 as of Jul. 14, 2026, which is 2% above its 10-year median of 5.27. GuruFocus rates MIL:1A with a GF Score™ of 70/100 and a GF Value™ of €127.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 201 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 71.14% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Agilent Technologies's share price is €117.45.
Agilent Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was €21.77. Hence, Agilent Technologies's PS Ratio for today is 5.40.
The historical rank and industry rank for Agilent Technologies's PS Ratio or its related term are showing as below:
MIL:1A'
s PS Ratio Range Over the Past 10 Years
Min: 3.45 Med: 5.27 Max: 9
Current: 5.27
During the past 13 years, Agilent Technologies's highest PS Ratio was 9.00. The lowest was 3.45. And the median was 5.27.
MIL:1A's PS Ratio is ranked worse than 71.14% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.81
vs MIL:1A: 5.27
Agilent Technologies Inc has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Agilent Technologies was 10.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.
During the past 13 years, Agilent Technologies's highest 3-Year average Revenue per Share Growth Rate was 18.40% per year. The lowest was -22.90% per year. And the median was 4.70% per year.
Back to Basics: PS Ratio
Agilent Technologies (MIL:1A) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Agilent Technologies PS Ratio Related Terms
Agilent Technologies PS Ratio Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Agilent Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Agilent Technologies's Share Price of today is €117.45. Agilent Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Agilent Technologies (MIL:1A) has a PS Ratio of 5.40 as of Jul. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 5.27. Over the past decade, Agilent Technologies' PS Ratio has ranged from 3.45 to 9.00. According to the industry distribution chart, Agilent Technologies ranks #143 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 71.1%.
Is Agilent Technologies' PS Ratio too high?
Agilent Technologies' current PS Ratio of 5.40 is near median its 10-year median of 5.27. Over the past 10 years, this metric has ranged from a low of 3.45 to a high of 9.00. The Medical Diagnostics & Research industry median PS Ratio is 2.81. Agilent Technologies' value of 5.40 is 92.2% above this industry median. Based on the distribution chart, Agilent Technologies ranks #143 out of 201 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' PS Ratio compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #143 out of 201 companies for PS Ratio. This places Agilent Technologies in the lower half of its industry. The industry median PS Ratio is 2.81. Agilent Technologies' value of 5.40 is 92.2% above this benchmark. Historically, Agilent Technologies' own PS Ratio has ranged from 3.45 to 9.00 over the past decade. While the company's 10-year median is 5.27 vs. the industry median of 2.81, Agilent Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.81, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current PS Ratio of 5.40 is 92.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current PS Ratio is 5.40, which is near median its own 10-year median of 5.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (MIL:1A) is currently considered Fairly Valued. The stock's GF Value™ is €127.82, compared to a current price of €117.45 — trading 8.1% below its estimated fair value. The current PS Ratio is 5.40, which is near median its 10-year median of 5.27 and 92.2% above the Medical Diagnostics & Research industry median of 2.81. Agilent Technologies' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Agilent Technologies (MIL:1A), the current PS Ratio is 5.40 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MIL:1A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €117.45 is trading 8.1% below its estimated GF Value™ of €127.82.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for MIL:1A:
PS Ratio: 5.40 (near median its 10-year median of 5.27)
GF Value™: €127.82 vs. price of €117.45 (8.1% below fair value)
Industry Position: 92.2% above the Medical Diagnostics & Research median (#143 of 201)
No single metric tells the full story. See the MIL:1A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
70GF Score
Get the complete analysis for MIL:1A
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1A has been successfully added to your 
